Navigation Links
Smelly socks could be a key to preventing malaria deaths in the developing world
Date:7/12/2011

Grand Challenges Canada announces a grant today to support further development of a new innovative device to attract and kill mosquitoes that can transmit malaria.

Developed by Dr. Fredros Okumu (Ifakara Health Institute, Tanzania), the device is placed outside the home and is the outdoor complement to bed nets and sprays which protect people from infection in their homes.

"Despite global progress in the fight against malaria, there is still work to be done," said Dr. Fredros Okumu, Ifakara Health Institute. "Malaria has claimed so many lives, including those of people close to me, and my hope is that this innovative device will be part of the solution."

The scientific team at Ifakara Health Institute has learned that the most effective way to attract mosquitoes to the device is the odour of smelly socks or similar smelling synthetic bait developed at the Institute. Both the socks and the bait are highly effective and attract four times more mosquitoes than a human being does. Once the mosquitoes are in the device, they are trapped or poisoned and left to die.

"Each year, there are almost 250 million new cases of malaria; almost 800,000 people die, and most of those deaths are children," says Dr. Peter A. Singer, Chief Executive Officer of Grand Challenges Canada. "This local Tanzanian innovation could contribute significantly to accelerating the elimination of malaria and save lives. Grand Challenges Canada is pleased to support Dr. Okumu's important discovery and further optimize this device, test its potential for impact and if successful identify a path to further development and commercialization to ensure the device is available to communities at a low cost."

"Through a lifetime of hard lessons, I know that discovery is not enough," said Joseph L. Rotman, the philanthropist and businessman who Chairs Grand Challenges Canada's Board of Directors. "Discoveries also need to be implemented in the real world through business and social innovation."

This initiative is a demonstration of Grand Challenges Canada's Integrated Innovation approach. Integrated Innovation is the coordinated application of scientific/technological, social and business innovation to develop solutions to complex challenges. Through this approach, the discovery has an improved opportunity of going to scale so that many more people benefit from the innovation.

Dr. Okumu's grant, funded jointly by Grand Challenges Canada and the Bill & Melinda Gates Foundation, will support research into testing and improving the device with the expectation it will be developed by the community in two years. Dr. Okumu's grant is one of twelve Grand Challenges Explorations Phase II grants announced today by the Gates Foundation.

"Grand Challenges Canada is a key partner in our effort to catalyze innovative scientific thinking and to encourage others to join in this effort," said Chris Wilson, the director of the Global Health Discovery program at the Gates Foundation. "Partnerships like this one will be critical in turning innovative ideas and early-stage research into new solutions for those most in need."

Grand Challenges Canada is funded by Canada's foreign aid budget. Canada is the first country in the world to take a grand challenges approach to international development.

The money to fund this Grand Challenges Canada grant comes from the Development Innovation Fund. In Budget 2008, the Government of Canada committed $225 million CAD over five years to the Development Innovation Fund, to support the best minds in the world in a collaborative search for solutions to global health challenges.


'/>"/>

Contact: Terry Collins
tc@tca.tc
416-538-8712
McLaughlin-Rotman Centre for Global Health
Source:Eurekalert

Related biology news :

1. Super socks help stem pollution runoff
2. Compost filter socks improve runoff from croplands
3. Nitric oxide-releasing wrap for donor organs and cloth for therapeutic socks
4. Knocking nanoparticles off the socks
5. University of Kentucky-led research could be path to new energy sources
6. Microalgae could be Texas next big cash crop
7. A mothers salt intake could be key to prenatal kidney development
8. New laser technology could kill viruses and improve DVDs
9. Termites digestive system could act as biofuel refinery
10. Could ovarian stimulation cause an increase in oocyte chromosome abnormalities?
11. Frog feet could solve a sticky problem
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2016)... -- VoiceIt is excited to announce its new marketing ... working together, VoiceIt and VoicePass will offer an ... slightly different approaches to voice biometrics, collaboration between ... Both companies ... "This marketing and technology partnership allows VoiceIt ...
(Date:5/3/2016)... , May 3, 2016  Neurotechnology, a ... the MegaMatcher Automated Biometric Identification System (ABIS) ... large-scale multi-biometric projects. MegaMatcher ABIS can process multiple ... using any combination of fingerprint, face or iris ... MegaMatcher SDK and MegaMatcher Accelerator , ...
(Date:4/26/2016)... -- Research and Markets has announced the ...  report to their offering.  , ,     (Logo: ... forecast the global multimodal biometrics market to grow ... 2016-2020.  Multimodal biometrics is being implemented ... healthcare, BFSI, transportation, automotive, and government for controlling ...
Breaking Biology News(10 mins):
(Date:6/24/2016)... , June 24, 2016 Epic Sciences ... detects cancers susceptible to PARP inhibitors by targeting ... cells (CTCs). The new test has already been ... in multiple cancer types. Over 230 ... damage response pathways, including PARP, ATM, ATR, DNA-PK ...
(Date:6/23/2016)... , ... June 23, 2016 , ... ... release of its second eBook, “Clinical Trials Patient Recruitment and Retention Tips.” Partnering ... retention in this eBook by providing practical tips, tools, and strategies for clinical ...
(Date:6/23/2016)... June 23, 2016 /PRNewswire/ - FACIT has announced ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" ... commercialization of a portfolio of first-in-class WDR5 inhibitors ... such as WDR5 represent an exciting class of ... precision medicine for cancer patients. Substantial advances have ...
(Date:6/23/2016)... Lawrence, MA (PRWEB) , ... June 23, 2016 ... ... the Peel Plate® YM (Yeast and Mold) microbial test has received AOAC Research ... test platform of microbial tests introduced last year,” stated Bob Salter, Vice President ...
Breaking Biology Technology: